Navigation Links
Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
Date:5/4/2012

including ADHD, major depressive disorder, and negative symptoms of schizophrenia."

Vyvanse is a prescription medicine currently approved in the United States and Canada, as well as in Brazil under the name Venvanse, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Vyvanse should be used to treat only ADHD.

Vyvanse is a Schedule II controlled substance. Stimulants, such as amphetamines and methylphenidates, are subject to misuse, abuse, addiction, and criminal diversion. Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events.

INTUNIV is indicated for the treatment of ADHD as monotherapy and as adjunctive therapy to stimulant medications in children and adolescents ages 6 to 17. The effectiveness of INTUNIV for more than 9 weeks has not been systematically evaluated. The physician electing to use INTUNIV for extended periods should periodically reevaluate its long-term usefulness for the individual patient.

Patients with a history of hypersensitivity to INTUNIV, its inactive ingredients, or other products containing guanfacine (eg, TENEX®) should not take INTUNIV.

Both Vyvanse and INTUNIV are indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

Highlights of the scientific presentations are noted below. Information about scientific presentations mentioned in this release is embargoed until the respective presentation sessions have taken place at the meeting.

ADHD Presentations

Lisdexamfetamine Dimesylate

  • May 5, 2012; 11:00 am to 12:30 pm EDT
    Duration of Action of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Scientific and Clinical Report #2 (Oral Presentation) - Location: 109B, Level 1
  • May 6, 2012; 1:00 pm to 3:00 pm EDT
    Effect of Li
    '/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy ... are considered the most sensitive method for detecting colorectal ... in preventing cancer cases 3 . EndoChoice ® ... Fuse™ system significantly improves the accuracy of this procedure ... colonoscopists. EndoChoice will be discussing these clinical trial results ...
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013 Medical devices ... nor a biological product. In light of their different ... evaluations are much more complicated than drug trails due ... evaluates MD safety instead of evaluating both safety and ... US FDA (which is the same as the SFDA) ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2
... 9, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... third quarter ended September 30, 2011. (Logo: ... third quarter of 2011 were $83.8 million, compared to $86.4 ... year-over-year decrease. Total revenues for the nine months ended September ...
... Nov. 9, 2011 Volcano Corporation (NASDAQ: ... guidance therapy tools designed to enhance the treatment of ... Intravascular Ultrasound (IVUS) and Fractional Flow Reserve (FFR) technologies ... patients undergoing percutaneous coronary intervention (PCI). The update was ...
Cached Medicine Technology:PDL BioPharma Announces Third Quarter 2011 Financial Results 2PDL BioPharma Announces Third Quarter 2011 Financial Results 3PDL BioPharma Announces Third Quarter 2011 Financial Results 4PDL BioPharma Announces Third Quarter 2011 Financial Results 5PDL BioPharma Announces Third Quarter 2011 Financial Results 6PDL BioPharma Announces Third Quarter 2011 Financial Results 7PDL BioPharma Announces Third Quarter 2011 Financial Results 8PDL BioPharma Announces Third Quarter 2011 Financial Results 9PDL BioPharma Announces Third Quarter 2011 Financial Results 10PDL BioPharma Announces Third Quarter 2011 Financial Results 11Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 2Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 3
(Date:5/20/2013)... 2013) Research presented at Digestive Disease Week (DDW) ... diarrhea (IBS-D) and hepatitis C. , An international ... In the phase II study, researchers found that the ... percent of the individuals treated. , "While there,s ... with constipation, we haven,t seen the same in IBS ...
(Date:5/20/2013)... disease (IBD) are at higher risk of melanoma, a ... Researchers found that IBD is associated with a 37 ... presented at the Digestive Disease Week 2013 conference in ... Crohn,s disease or ulcerative colitis (UC), the most common ... lining of the intestine, leading to bouts of watery ...
(Date:5/20/2013)... novel service for personalized research counseling was launched recently by ... field of providing expert research support services since a decade. ... to maintain a direct contact with mentors and get customized ... at $1000. , Students who opt for the new service ... will handle all aspects. Scholars will be assisted for choosing ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Maui’d Forever is ... and coordinator. Founded in 2003 by entrepreneur Mark Steffan, the ... and the Big Island of Hawaii. They use over 150 ... additional members to their team. , They are happy to ... Chef Kathy Morris. Kathy is an extraordinary chef and is ...
(Date:5/20/2013)... 2013 Main Virtual Office , ... with several Mathnasium franchisee's to provide live answering services ... can we answer and transfer their calls according to ... scheduling at a fraction of what they were being ... Main Virtual Office. "Core competency is critical" says ...
Breaking Medicine News(10 mins):Health News:Pharmaceutical advances offer new options for health outcomes 2Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:Maui'd Forever Uses New Chef for Receptions and Special Private Beach Dinners 2Health News:Virtual Assistant and Mobile App Company - Main Virtual Office - Signs Up Several New Mathnasium Tutoring Centers 2
... updates the NCCN Guidelines for Non-Small Cell Lung Cancer to ... specific patients with Non-Small Cell Lung Cancer, and a revised ... National Comprehensive Cancer Network (NCCN) recently updated the ... a new section about maintenance therapy, a number of new ...
... Convention and Preconvention Program, the only medical imaging conference ... medical ultrasound, to be held March 24-27, 2010, in ... emerging applications and unique opportunities for collaboration between physicians, ... and expand into new arenas. With a ...
... the number of children diagnosed with autistic spectrum disorders over ... have found a sharp difference between the beliefs of ordinary ... incidence of autism. Expert consensus is that the rapid ... many lay people directly or indirectly affected by the disorder ...
... Group evaluated the achievements at EU level in combating ... EU cannot turn its back on CVD", expressed Dirk ... the MEP Heart Group. There is overwhelming evidence that ... It is therefore the task of decision makers at ...
... of vitamin E in the nuts, expert says , WEDNESDAY, ... reduce your risk for lung cancer and other malignancies, according ... of a type of vitamin E called gamma-tocopherol. , "It ... against certain forms of cancer. Higher intakes of gamma-tocopherol ... ...
... CORD:USE Cord Blood Bank is proud to announce that ... Department of Health and Human Services has awarded CORD:USE Cord ... supply of cord blood units for the National Cord Blood ... a prestigious designation which further validates the procedures and operations ...
Cached Medicine News:Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2Health News:People affected by autism believe increase is 'real,' not diagnostic 2Health News:Want to Cut Cancer Risk? Try Munching Pistachios 2Health News:CORD:USE Cord Blood Bank Receives Grant From HRSA to Increase the National Cord Blood Inventory 2
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... Dryer incorporates sturdy metal housing and TEFLON coated heating ... area makes it perfect for drying down large sequencing ... 40cm x 50cm (W x D) work surface ... you to optimize your heating to your gel ...
... compact air gel-drying system, Hoefers Easy Breeze can dry ... cm) or 24 Mini-Gels (8 x 10 cm) at ... an open air drying oven, a specially designed loading ... no cold trap, no awkward connections., The Gel Frame ...
Medicine Products: